Icon Plc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
2.7%projected annual EPS growth
Analyst Coverage
16analysts covering
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 27 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Net Bookings Quarterly2.9B
Net Book-to-Bill Ratio Quarterly136.0%
Total Backlog Quarterly21.8B
Watch Items
- Implementation of internal financial reporting control remediation planTrigger: Audit Committee review of material weakness remediation progressAction: Evaluate effectiveness of newly implemented revenue recognition controls and backlog policies
- Clinical trial cancellation ratesTrigger: Cancellations exceeding historical normalized levelsAction: Assess impact on full-year revenue guidance and adjust operational capacity accordingly
Research as of 2 Sep 2026